LATEST ALERTS
Justifications for public vaping bans largely revolve around re-normalisation of conventional smoking as well as the possible health impact of secondhand vaping.
Professor Linda Bauld, an expert in public health policy, has criticised a number of articles reporting on evidence she gave to the devolved governments of Scotland saying they completely misrepresent her position.
Hungary’s transposition of the EU Tobacco Products Directive will do away with the current mandatory pharmaceutical licensing requirement for e-cigarettes – which has resulted in no nicotine-containing products being legal in the country – and allow them to be sold as consumer products. As this great change approaches, our in-depth report on Hungary includes: Regulatory landscape • Current national regulatory framework • Age restrictions • Packaging and product restrictions • Notification requirements • Retailing restrictions (including cross-border and distance sales) • Public usage • Advertising and marketing restrictions • Taxation • Case law • Enforcement • The missing pieces of the TPD jigsaw • Graphic: how Hungarian e-cigarette regulation will change
Executive summary • Introduction • Why an electronic nicotine delivery system (ENDS) product requires a PMTA: distinction among ENDS products, components/parts, and accessories; three pathways to market approval; concerns about the grandfather date • Guidance for industry: information on premarket tobacco product applications (PMTA) and the submission process • Public health considerations: scientific evidence, comparative analysis, voluntary restrictions on sale and distribution, nicotine exposure warnings, child-resistant packaging, alternatives to new scientific studies, government-sponsored databases, non-U.S. randomised controlled clinical trials, literature reviews or reports • FDA enforcement for manufacturers and retailers: enforcement limited to finished tobacco products; independent vapour shops considered as tobacco product manufacturers • Appendix 1: definitions • Appendix 2: submitting a PMTA
Regulators, health professionals and scientists are expected to converge in London this week for an update on research into vaping.
The first convincing evidence of a causal link between under-age vaping and tobacco use has delivered a shock to those who favour banning sales to minors: e-cigarettes may actually reduce teen smoking.
There may be more recent ECigIntelligence reports on this territory. Please visit the home page for the United Kingdom or the advanced search page. Introduction The central government has started to transpose the Tobacco Products Directive (TPD). At the same time, the regional government of Wales wants to impose a smoking-style public place usage restriction while Scotland plans to ban the » Continue Reading.
There may be more recent ECigIntelligence reports on this territory. Please visit the home page for the United Kingdom or the advanced search page. To provide further insight on the developing UK regulatory scene for e-cigarettes, we have collated this in-depth companion to Regulatory report: UK gears up for fragmented TPD transposition for ECigIntelligence readers. Section 1 – Relevant consumer » Continue Reading.
One in eight adult Americans has tried an e-cigarette, according to the federal government’s Centers for Disease Control and Prevention (CDC), though only 3.7% are still using them.
A team of tobacco control scholars has come under fire for omitting an important finding on e-cigarettes from the abstract of their latest scientific paper.
A French government agency found significant irregularities in tested e-liquid samples and e-cigarette chargers.
As the U.S. e-cig industry and policy-makers alike await the final version of the Food and Drug Administration’s deeming regulations, two conferences will be held in the Washington area next week to discuss a spectrum of issues related to tobacco and nicotine policies.
Regulators should set a standard methodology for the pharmacokinetic tests that measure how much nicotine is in vapers’ or smokers’ blood, say scientists at British American Tobacco (BAT).
A new Welsh survey has found little use of e-cigarettes among consumers who have never smoked. But is the evidence enough to prevent a proposed public vaping ban from coming into force?
Introduction • Regulatory landscape • Current national regulatory framework • National regulatory framework post-TPD • Age restrictions • Product restrictions • Ingredients • Labelling and packaging • Product notification • Annual reporting • Vigilance • Retailing • Public usage • North Rhine-Westphalia • Bavaria • Baden-Württemberg • Lower Saxony • Hesse • Public usage: an inconsistent future? • Advertising and marketing • Taxation • Enforcement • Case law: e-cigarettes as medical products • Case law: e-cigarettes as tobacco products • Case law: tobacco advertising restrictions • The missing pieces from the TPD jigsaw • Graphic: how German e-cigarette regulation will change
Experienced users should not be dismissed as unreliable sources of insight when e-cigarettes are being discussed, and their advice can be valuable for those just starting to vape or considering it, according to a British researcher.
The number and strength of chemicals absorbed in the blood of e-cigarette users is dramatically lower than in those who smoke tobacco, according to a new test of exhaled breath.
Looking like a regular cigarette is an advantage for e-cig products aiming to poach users away from tobacco, new research suggests.
A new study carried out in Hawaii is said to be the first “to attempt to elucidate the contexts of e-cigarette and cigarette use among dual users”, examining issues ranging from consumption patterns to motivations.
Two of vaping’s most eminent scientific advocates have called for bespoke regulatory regimes that follow neither the tobacco nor the pharmaceutical model, but they acknowledge that formulating appropriate rules can be a “very challenging process”.
While some critics fear that exposure to e-cigarettes and e-cig advertising among young people can lead to them taking up nicotine, a new study in Scotland suggests that awareness doesn’t always mean action.
An American public health organisation has declared that there is insufficient evidence to approve e-cigarettes as aids for smoking cessation.
The U.S. Food and Drug Administration (FDA) is this week proposing a new rule that will make it clearer when tobacco products should be considered as drugs or medical devices, and regulated accordingly.
Counterblasts against Public Health England’s nearly unequivocal support for e-cigarettes were only to be expected, and their trajectory has been laid out by two of Britain’s most eminent general medical journals, The Lancet and The BMJ. But their arguments are neither nuanced nor practical, and are muddled by dislike of the tobacco industry.
Executive summary • Introduction • FDA enforcement authority • Development of FDA e-cigarette enforcement • Compliance strategies for the industry • Risk posed by patents
The Irish government has decided not to extend the country’s smoking ban to e-cigarettes, citing the lack of evidence for harm – but the advertising self-regulatory body in Ireland has taken a slightly harder line.
There has been little study or comment on e-cigs so far from professional bodies in dental health, or from dental researchers.
But that may now be changing, with increased interest from some corners of the dental profession in e-cigs’ role as potential reducers of harm to oral health.
The U.S. National Park Service (NPS) has banned the use of electronic cigarettes in park concessions, as well as within all government facilities and vehicles. But the prohibition does not apply outdoors.
U.S. president Barack Obama has chosen Rob Califf, currently the deputy commissioner for medical products and tobacco at the Food and Drug Administration (FDA), to head up the agency.
British politicians this week heard praise from e-cigarette advocates for the recent endorsement of e-cigs by Public Health England (PHE), but some proponents argued that PHE’s backing was too little too late and failed to address serious short-term problems that they believe the industry faces in the UK.
Introduction • Regulatory landscape • Current regulatory framework • Product categorisation • Age restrictions • Product restrictions • Notification procedure • Public usage • Advertising and marketing restrictions • Cross-border sales • Taxation • Case law • Enforcement • Conclusions • Graphic: how Portuguese e-cigarette regulation will change
Differing limits set by e-cigarette manufacturing associations for diacetyl and acetylpropionyl in e-liquids seem likely to lead to confusion and acrimony.
The U.S. Food and Drug Administration (FDA) has warned tobacco companies including R.J. Reynolds and Imperial Tobacco to stop describing some of their combustible cigarettes as “additive-free” or “natural”.
Governments of poorer countries need to regulate e-cigarettes just as much as their wealthier counterparts, and ought to opt for a pharmaceutical model – but they may find it difficult, according to a new paper by two U.S. academics.
Public Health England has voiced its support for e-cigarettes backed by newly commissioned research into their potential impact on consumer health and use in harm reduction as well as smoking cessation.
The east African nation of Uganda appears to have become one of the small handful that ban e-cigarettes altogether, rolling a blanket prohibition into a stiff new tobacco control act.
Regulatory landscape • Current national regulatory framework • Age restrictions • Packaging and product restrictions • Public usage • Advertising and marketing restrictions • Case law • Taxation • Enforcement • The future • Graphic: how Bulgarian e-cigarette regulation will change
New studies attempting to determine causes of youth e-cigarette use have found some correlation with factors such as vaping or smoking by other household members, peer pressure, economic deprivation and ethnicity.
A prominent British public-health charity has thrown its weight behind vaping, saying that the public needs educating on e-cigarettes’ health benefits compared with combustibles.
Our review of the top e-cigarette regulatory stories recently in the news.
Researchers in the U.S. have developed a model for predicting the amount of nicotine emitted by e-cigarettes, which they say could gauge the expected yield of a device before it is even built.
Californian senator Mark Leno’s e-cigarette bill is back, despite seeming to have died last month after a legislative committee tore out some of its most significant measures.
An in-depth look at the regulation and legislation ruling the South Korean e-cigarette market.
Among all the groups that could benefit from e-cigarettes for harm reduction, perhaps none is as contentious as pregnant women.
ECigIntelligence next month launches ECigIntelligence Platinum, the most comprehensive package of regulatory and business information available for the e-cigarette market anywhere in the world.
Infographic showing how the level of e-cigarette regulation in different territories appears to have an impact on vaping prevalence.
Only about one in 30 Americans fully understand the relative health risks of different nicotine products, according to a new study.
A Florida cancer research centre has been given $3.6m (€3.3m) for a long-running study of how e-cigarettes are used by consumers and whether they help vapers quit tobacco.
State governments in Australia and the U.S. are moving to stop the use of e-cigarettes in cars where children are present.
The U.S. Food and Drug Administration (FDA) is considering new rules that could require manufacturers of e-liquids and other products to child-proof their packaging and affix warnings about nicotine poisoning.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
